Macrogenics (MGNX) Change in Account Payables (2012 - 2017)
Macrogenics' (MGNX) quarterly Change in Account Payables came in at $197000.0 in Q2 2017, up 496.97% year-on-year from $33000.0 in Q2 2016, and up 108.86% on a QoQ basis from -$2.2 million in Q1 2017.
Macrogenics (MGNX) Change in Account Payables (2012 - 2017) Analysis & Trends
Macrogenics (MGNX) has 6 years of Change in Account Payables data on file, last reported at $197000.0 in Q2 2017.
- On a quarterly basis, Change in Account Payables rose 496.97% year-over-year to $197000.0 in Q2 2017; TTM through Jun 2017 was $561000.0, a 179.91% increase from a year earlier, with the FY2025 full-year figure at -$280000.0, up 81.7% from the prior year.
- Change in Account Payables for Q2 2017 stood at $197000.0, up from -$2.2 million in the prior quarter.
- Over the last five years, Change in Account Payables for MGNX reached as high as $2.4 million in Q4 2016 and fell as low as -$2.7 million in Q4 2014.
- Historically, Change in Account Payables has averaged -$112611.1 across 5 years, with a median of -$96000.0 in 2015.
- On a YoY basis, Change in Account Payables climbed as much as 496.97% in 2017 and fell as far as 472.94% in 2017.
- Year by year, Change in Account Payables stood at $1.4 million in 2013, then slumped by 298.32% to -$2.7 million in 2014, then jumped by 61.93% to -$1.0 million in 2015, then jumped by 328.5% to $2.4 million in 2016, then sank by 91.67% to $197000.0 in 2017.
- Per Business Quant data, the three most recent Change in Account Payables figures were $197000.0 in Q2 2017, -$2.2 million in Q1 2017, and $2.4 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 197,000.00 |
| Jun 30, 2017 | 197,000.00 |
| Mar 31, 2017 | -2.22 Mn |
| Mar 31, 2017 | -2.22 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Dec 31, 2016 | 2.37 Mn |
| Sep 30, 2016 | 222,000.00 |
| Sep 30, 2016 | 222,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Mar 31, 2016 | -388,000.00 |
| Dec 31, 2015 | -1.04 Mn |
| Dec 31, 2015 | -1.04 Mn |
| Sep 30, 2015 | 688,000.00 |
| Sep 30, 2015 | 688,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Jun 30, 2015 | 409,000.00 |
| Mar 31, 2015 | -225,000.00 |
| Mar 31, 2015 | -225,000.00 |